Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the change in brachial artery reactivity in
HIV-infected subjects with elevated lipid levels who are switched to an atazanavir containing
antiretroviral regimen